跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Vimpat
Approved
STANDARD
Vimpat
UCB Pharma GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
09eda78a8a409b84
Company
UCB Pharma GmbH
Type
Standard
Approval Details
Approval Id
09eda78a8a409b84
Drug Approval Philippines Name
Vimpat
Product Name
Vimpat
Registration Number
DR-XY45798
Brand Name
Vimpat
Generic Name
Lacosamide
Dosage Form
Solution for IV Infusion
Dosage Strength
10 mg/mL
Manufacturer
UCB Pharma GmbH
Importer
Abbott Laboratories
Distributor
Abbott Laboratories
Company Detail Path
/organization/ucb-pharma-gmbh
Importer Detail Path
/organization/abbott-laboratories
Distributor Detail Path
/organization/abbott-laboratories
Issuance Date
15 August 2024
Expiry Date
15 August 2029
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
09eda78a8a409b84
Type
Standard
Back to Philippines FDA Approvals
Vimpat - Philippines FDA Drug Approval Details